SXTC — China SXT Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
- $1.01m
- -$12.91m
- $1.97m
- 21
- 74
- 10
- 28
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 1.54 | -10.3 | -2.75 | -5.74 | -5.93 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0.067 | 9.05 | 2.89 | 2.89 | 4.19 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.54 | 1.95 | -1.61 | 2.46 | 1.42 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 0.239 | 0.934 | -1.32 | 0.268 | -0.081 |
Capital Expenditures | -0.61 | -0.407 | -0.093 | -0.062 | -0.071 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | -5.09 | -5.71 | 0.016 | 0.058 |
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.61 | -5.5 | -5.81 | -0.047 | -0.012 |
Financing Cash Flow Items | 2.52 | -3.7 | 12.5 | -3.84 | -3.26 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 9.04 | 3.02 | 12.4 | 1.6 | 2.94 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 8.63 | -2 | 6.07 | 2.21 | 1.8 |